<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Matrix Biol</journal-id>
      <journal-title-group>
        <journal-title>Matrix Biology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0945-053X</issn>
      <issn pub-type="epub">1569-1802</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3004031</article-id>
      <article-id pub-id-type="pmid">20619343</article-id>
      <article-id pub-id-type="publisher-id">MATBIO806</article-id>
      <article-id pub-id-type="doi">10.1016/j.matbio.2010.06.007</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Modulatory effect of interleukin-1α on expression of structural matrix proteins, MMPs and TIMPs in human cardiac myofibroblasts: Role of p38 MAP kinase</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Turner</surname>
            <given-names>Neil A.</given-names>
          </name>
          <email>n.a.turner@leeds.ac.uk</email>
          <xref rid="af0005" ref-type="aff">a</xref>
          <xref rid="af0010" ref-type="aff">b</xref>
          <xref rid="cr0005" ref-type="corresp">⁎</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Warburton</surname>
            <given-names>Philip</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">a</xref>
          <xref rid="af0010" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>O'Regan</surname>
            <given-names>David J.</given-names>
          </name>
          <xref rid="af0010" ref-type="aff">b</xref>
          <xref rid="af0015" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ball</surname>
            <given-names>Stephen G.</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">a</xref>
          <xref rid="af0010" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Porter</surname>
            <given-names>Karen E.</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">a</xref>
          <xref rid="af0010" ref-type="aff">b</xref>
        </contrib>
      </contrib-group>
      <aff id="af0005"><label>a</label>Division of Cardiovascular and Neuronal Remodelling, Leeds Institute of Genetics, Health and Therapeutics (LIGHT), University of Leeds, Leeds, UK</aff>
      <aff id="af0010"><label>b</label>Multidisciplinary Cardiovascular Research Centre (MCRC), University of Leeds, Leeds, UK</aff>
      <aff id="af0015"><label>c</label>Department of Cardiac Surgery, The Yorkshire Heart Centre, Leeds General Infirmary, Leeds, UK</aff>
      <author-notes>
        <corresp id="cr0005"><label>⁎</label>Corresponding author. Division of Cardiovascular and Neuronal Remodelling, Worsley Building, Clarendon Way, University of Leeds, Leeds LS2 9JT, UK. Tel.: + 44 113 3435890; fax: + 44 113 3434803. <email>n.a.turner@leeds.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <month>9</month>
        <year>2010</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2010</year>
      </pub-date>
      <volume>29</volume>
      <issue>7-6</issue>
      <fpage>613</fpage>
      <lpage>620</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>12</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>22</day>
          <month>6</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>6</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2010 Elsevier B.V.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <copyright-holder>Elsevier B.V.</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>The proinflammatory cytokine interleukin-1 (IL-1) elicits catabolic effects on the myocardial extracellular matrix (ECM) early after myocardial infarction but there is little understanding of its direct effects on cardiac myofibroblasts (CMF), or the role of p38 mitogen-activated protein kinase (MAPK). We used a focused RT-PCR microarray to investigate the effects of IL-1α on expression of 41 ECM genes in CMF cultured from different patients, and explored regulation by p38 MAPK.</p>
        <p>IL-1α (10 ng/ml, 6 h) had minimal effect on mRNA expression of structural ECM proteins, including collagens, laminins, fibronectin and vitronectin. However, it induced marked increases in expression of specific ECM proteases, including matrix metalloproteinases MMP-1 (collagenase-1), MMP-3 (stromelysin-1), MMP-9 (gelatinase-B) and MMP-10 (stromelysin-2). Conversely, IL-1α reduced mRNA and protein expression of ADAMTS1, a metalloproteinase that suppresses neovascularization. IL-1α increased expression of TIMP-1 slightly, but not TIMP-2. Data for MMP-1, MMP-2, MMP-3, MMP-9, MMP-10 and ADAMTS1 were confirmed by quantitative real-time RT-PCR. Tumor necrosis factor-alpha (TNFα), another important myocardial proinflammatory cytokine, did not alter expression of these metalloproteinases. IL-1α strongly activated the p38 MAPK pathway in human CMF. Pharmacological inhibitors of p38-α/β (SB203580) or p38-α/β/γ/δ (BIRB-0796) reduced MMP-3 and ADAMTS1 mRNA expression, but neither inhibitor affected MMP-9 levels. MMP-1 and MMP-10 expression were inhibited by BIRB-0796 but not SB203580, suggesting roles for p38-γ/δ.</p>
        <p>In summary, IL-1α induces a distinct pattern of ECM protein and protease expression in human CMF, in part regulated by distinct p38 MAPK subtypes, affirming the key role of IL-1α and CMF in post-infarction cardiac remodeling.</p>
      </abstract>
      <kwd-group>
        <title>Abbreviations</title>
        <kwd>ADAMTS, a disintegrin and metalloproteinase domain with thrombospondin motifs</kwd>
        <kwd>CMF, cardiac myofibroblast</kwd>
        <kwd>DMSO, dimethylsulfoxide</kwd>
        <kwd>ECM, extracellular matrix</kwd>
        <kwd>GAPDH, glyceraldehyde-3-phosphate dehydrogenase</kwd>
        <kwd>HSP27, heat shock protein-27</kwd>
        <kwd>IL-1, intereukin-1</kwd>
        <kwd>MAPK, mitogen-activated protein kinase</kwd>
        <kwd>MI, myocardial infarction</kwd>
        <kwd>MMP, matrix metalloproteinase</kwd>
        <kwd>TIMP, tissue inhibitor of metalloproteinases</kwd>
        <kwd>TNF, tumor necrosis factor</kwd>
        <kwd>VEGF, vascular endothelial growth factor</kwd>
      </kwd-group>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Interleukin-1</kwd>
        <kwd>Matrix metalloproteinase</kwd>
        <kwd>Cardiac fibroblast</kwd>
        <kwd>Extracellular matrix</kwd>
        <kwd>p38 MAP kinase</kwd>
        <kwd>Microarray</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s0005">
      <label>1</label>
      <title>Introduction</title>
      <p>Interleukin-1 (IL-1) is one of the initial stimuli that drive the acute inflammatory response after myocardial infarction (MI) (<xref rid="bb0050" ref-type="bibr">Guillen et al., 1995</xref>). Release of IL-1α from necrotic cells is a key trigger for inflammation in the liver (<xref rid="bb0030" ref-type="bibr">Chen et al., 2007</xref>), and it is plausible that this cytokine plays a similar role in the myocardium following myocyte necrosis. Cardiomyocytes express IL-1α (<xref rid="bb0190" ref-type="bibr">Westphal et al., 2007</xref>) and IL-1α protein levels are increased in the infarcted myocardium following myocyte necrosis (<xref rid="bb0155" ref-type="bibr">Timmers et al., 2008</xref>). Moreover, transgenic mice with cardiac-specific overexpression of IL-1α develop left ventricular hypertrophy (<xref rid="bb0120" ref-type="bibr">Nishikawa et al., 2006</xref>), and those ubiquitously over-expressing IL-1α die of heart failure (<xref rid="bb0060" ref-type="bibr">Isoda et al., 2001</xref>).</p>
      <p>Cardiac fibroblasts are the most prevalent cell type in the heart and are key regulators of the myocardial extracellular matrix (ECM) (<xref rid="bb0125" ref-type="bibr">Porter and Turner, 2009</xref>). Activated cardiac fibroblasts, termed cardiac myofibroblasts (CMF), play an essential role in the early adaptive healing response that occurs following MI (<xref rid="bb0125 bb0185" ref-type="bibr">Porter and Turner, 2009; van den Borne et al., 2010</xref>). In this acute phase, CMF secrete proteolytic matrix metalloproteinases (MMPs) that degrade the structural components of the ECM, permitting recruitment of inflammatory cells and CMF to the infarct areas and facilitating neovascularization. Subsequently, CMF synthesize new ECM protein (predominantly fibrillar collagens I and III) to form a scar, and actively contract the edges of the wound area. Thus, CMF play a key role in the early remodeling of the heart following MI and undergo transformation from an ECM-degrading phenotype to an ECM-synthesizing phenotype. Understanding the extracellular cues that drive these distinct processes at the level of the CMF is paramount for designing targeted therapeutic strategies that encourage infarct healing without promoting overt fibrosis.</p>
      <p>There is strong evidence that the p38 mitogen-activated protein kinase (MAPK) pathway exacerbates myocardial injury following prolonged ischemia (<xref rid="bb0035" ref-type="bibr">Clark et al., 2007</xref>). Proinflammatory cytokines whose levels are elevated in the infarcted heart, such as IL-1 and tumor necrosis factor-alpha (TNFα), are potent stimuli for the p38 MAPK pathway and transgenic mice with cardiomyocyte-specific overexpression of IL-1α display increased myocardial p38 MAPK activity (<xref rid="bb0120" ref-type="bibr">Nishikawa et al., 2006</xref>). However, despite the key role of CMF in the myocardial remodeling process, very little is known about the role of the p38 MAPK pathway in modulating CMF function. There are four known p38 MAPK subtypes; p38-α (SAPK2a), p38-β (SAPK2b), and the more distantly related p38-γ (SAPK3) and p38-δ (SAPK4). Many studies ascribing roles to p38 MAPK have employed pyridinyl imidazole compounds (e.g. SB203580) as selective p38 MAPK inhibitors (<xref rid="bb0035" ref-type="bibr">Clark et al., 2007</xref>); although strictly speaking these agents inhibit only the α and β subtypes. In contrast, the diaryl urea compound BIRB-0796 inhibits all four p38 subtypes with similar efficacy (<xref rid="bb0075" ref-type="bibr">Kuma et al., 2005</xref>).</p>
      <p>In this study we used a focused RT-PCR microarray to investigate the effects of IL-1α on expression of 41 ECM genes in human CMF, including structural ECM proteins, metalloproteinases and tissue inhibitors of metalloproteinases (TIMPs). We then determined the role of the p38 MAPK pathway in mediating IL-1α-induced changes in gene expression of key ECM proteases.</p>
    </sec>
    <sec id="s0010">
      <label>2</label>
      <title>Results</title>
      <sec id="s0015">
        <label>2.1</label>
        <title>Microarray analysis of IL-1-induced mRNA expression of ECM proteins and proteases</title>
        <p>A SYBR Green-based real-time PCR array approach was used to investigate the effects of the proinflammatory cytokine IL-1α (10 ng/ml, 6 h) on mRNA expression of 41 ECM genes in cultured human CMF, including 23 structural proteins (collagens, laminins, fibronectin, vitronectin), 12 MMPs, 3 members of the ADAMTS (a disintegrin and metalloproteinase domain with thrombospondin motifs) family and 3 TIMPs. CMF from 3 different patients were employed in the array analysis to identify reproducible responses to IL-1α. Array data, expressed relative to mRNA levels of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH), are presented in <xref rid="t0005" ref-type="table">Table 1</xref> (structural ECM proteins) and <xref rid="t0010" ref-type="table">Table 2</xref> (ECM proteases and TIMPs).</p>
        <p>Relatively high mRNA expression levels of multiple ECM proteins were observed in CMF under basal conditions, including collagen types I, IV, V, VI, VIII, XII and XIV, laminins α2, β1 and γ1, and fibronectin (<xref rid="t0005" ref-type="table">Table 1</xref>). By far the most highly expressed transcript was that of fibronectin, with collagen type VI also being prevalent. Treatment of CMF with IL-1α (6 h) did not affect levels of these highly expressed mRNAs, but did appear to have modulatory effects on some of those with lower basal levels (<xref rid="t0005" ref-type="table">Table 1</xref>). For example, IL-1α increased mRNA levels of hyaluronan synthase (7.5-fold), type VII collagen (5-fold) and laminin β3 (2-fold), and decreased mRNA levels of collagen type XV (60% reduction) and laminin α1 (75% reduction).</p>
        <p>We next analyzed expression of a range of ECM proteases and TIMPs in human CMF (<xref rid="t0010" ref-type="table">Table 2</xref>). CMF expressed relatively high levels of ADAMTS1, MMP-2, MMP-1, MMP-14 and MMP-16 under basal conditions. TIMP-1 and TIMP-2 mRNA were expressed at much higher levels than the MMPs, but TIMP-3 transcripts were not detected. Treatment of CMF with IL-1α for 6 h increased mRNA levels of MMP-9 (200-fold), MMP-3 (150-fold), MMP-10 (90-fold), MMP-1 (8-fold) and to a lesser extent TIMP-1 (2-fold). In contrast, ADAMTS1, MMP-11 and MMP-16 mRNA levels were reduced 50–70% following IL-1α treatment. Four MMPs were undetectable at the mRNA level in control and IL-1α-stimulated CMF, namely MMP-7, MMP-8, MMP-13 and MMP-15.</p>
      </sec>
      <sec id="s0020">
        <label>2.2</label>
        <title>RT-PCR analysis of cytokine-induced metalloproteinase mRNA expression</title>
        <p>Overall analysis of the microarray data set revealed that the major effects of IL-1α were on expression of proteases, rather than the structural ECM proteins (<xref rid="t0005 t0010" ref-type="table">Tables 1 and 2</xref>). We therefore selected six protease genes for further study, four that were increased following IL-1α treatment (MMP-1, MMP-3, MMP-9, MMP-10), one that was reduced by exposure to IL-1α (ADAMTS1) and one that was expressed at high basal levels but unaltered by IL-1α treatment (MMP-2). CMF from 3 patients were treated with 10 ng/ml IL-1α for 2–6 h before extracting RNA and performing real-time RT-PCR with specific Taqman primer/probes sets for each protease (<xref rid="f0005" ref-type="fig">Fig. 1</xref>). These experiments confirmed the array results in terms of relative basal expression levels and the response to IL-1α (increased mRNA levels of MMP-1, -3, -9 and -10, decreased levels of ADAMTS1 and no change in MMP-2). The time course experiments also revealed interesting differences in the temporal profile of mRNA expression for each protease (<xref rid="f0005" ref-type="fig">Fig. 1</xref>). The mRNA profiles for MMP-1 and MMP-10 peaked within 5 h, whereas those of MMP-3 and MMP-9 were still rising 6 h after IL-1α treatment. As expected, MMP-2 levels remained constant after IL-1α treatment. ADAMTS1 mRNA levels were reduced by 55–65% over the whole 2–6 h time period.</p>
        <p>The finding that IL-1α could reduce ADAMTS1 mRNA expression was of particular novelty, since this is the first description in cardiac fibroblasts. We therefore performed Western blotting experiments to determine whether IL-1α could also modulate ADAMTS1 expression at the protein level. As shown in <xref rid="f0010" ref-type="fig">Fig. 2</xref>, IL-1α reduced cellular expression of the zymogen form of ADAMTS1 protein (~ 120 kDa) by 50% 4–8 h after IL-1α stimulation. Protein levels of ADAMTS1 returned to near basal levels 24 h after treatment (<xref rid="f0010" ref-type="fig">Fig. 2</xref>).</p>
        <p>We next compared the relative potency of IL-1α with that of another important myocardial proinflammatory cytokine, TNFα, in inducing ECM protease expression in CMF (<xref rid="f0015" ref-type="fig">Fig. 3</xref>). TNFα treatment alone had little or no effect on MMP-1, MMP-3, MMP-9, MMP-10 or ADAMTS1 mRNA levels after 6 h, in marked contrast to the response to IL-1α. When both IL-1α and TNFα were added simultaneously, trends towards further increases in MMP-1, -3, -9 and -10 levels, and further decreases in ADAMTS1, were observed; however these were not statistically significant (<xref rid="f0015" ref-type="fig">Fig. 3</xref>). Neither IL-1α nor TNFα, alone or in combination, altered MMP-2 mRNA expression levels.</p>
      </sec>
      <sec id="s0025">
        <label>2.3</label>
        <title>Role of p38 MAPK in mediating IL-1-induced changes in metalloproteinase gene expression</title>
        <p>IL-1α stimulated the p38 MAPK pathway in CMF as evidenced by increased phosphorylation of p38 MAPK and the downstream substrate HSP27 (<xref rid="f0020" ref-type="fig">Fig. 4</xref>). The p38-α/β inhibitor SB203580 (10 μM) and the p38-α/β/γ/δ inhibitor BIRB-0796 (1 μM) effectively inhibited IL-1α-induced HSP27 phosphorylation, but did not inhibit p38 MAPK phosphorylation <italic>per se</italic> (<xref rid="f0020" ref-type="fig">Fig. 4</xref>); consistent with their mode of action as inhibitors of p38 activity (<xref rid="bb0035" ref-type="bibr">Clark et al., 2007</xref>).</p>
        <p>When CMF were pretreated with SB203580, an 80% reduction in IL-1α-induced MMP-3 mRNA expression was observed (<xref rid="f0025" ref-type="fig">Fig. 5</xref>). Similar results were obtained with BIRB-0796 (<xref rid="f0030" ref-type="fig">Fig. 6</xref>). Both SB203580 and BIRB-0796 reduced ADAMTS1 mRNA either in the absence or presence of IL-1α treatment (<xref rid="f0025 f0030" ref-type="fig">Figs. 5 and 6</xref>). In contrast, neither inhibitor modulated MMP-2 or MMP-9 mRNA expression (<xref rid="f0025 f0030" ref-type="fig">Figs. 5 and 6</xref>). Interestingly, BIRB-0796 reduced IL-1α-induced MMP-1 and MMP-10 mRNA levels by 70–80%, but SB203580 was without effect (<xref rid="f0025 f0030" ref-type="fig">Figs. 5 and 6</xref>).</p>
      </sec>
    </sec>
    <sec id="s0030">
      <label>3</label>
      <title>Discussion</title>
      <p>In this study we used a focused RT-PCR microarray to quantify the effects of IL-1α on expression of 41 ECM genes in human CMF. The majority of effects were on expression of metalloproteinases rather than structural ECM proteins. IL-1α (but not TNFα) increased mRNA expression of MMPs 1, 3, 9 and 10, and reduced expression of ADAMTS1 at both mRNA and protein levels. We also demonstrated that p38-α/β was important for IL-1α-induced MMP-3 expression and basal expression of ADAMTS1. Data obtained with BIRB-0796 suggested a role for additional p38 MAPK subtypes (γ or δ) in mediating IL-1α-induced MMP-1 and MMP-10 expression.</p>
      <p>IL-1 has been previously shown to reduce total collagen synthesis ([<sup>3</sup>H]-proline incorporation) in neonatal and adult rat cardiac fibroblasts (<xref rid="bb0145 bb0195" ref-type="bibr">Siwik et al., 2000; Xiao et al., 2008</xref>). More detailed Northern blot examination revealed that IL-1β decreased mRNA levels of fibrillar type I and III collagens, but increased expression of non-fibrillar type IV collagen and fibronectin mRNA after 24 h (<xref rid="bb0145" ref-type="bibr">Siwik et al., 2000</xref>). We observed only small decreases (&lt; 25%) in type I and type IV collagen expression in human CMF after 6 h IL-1α treatment. We did not study type III collagen as this was not included on the microarray. We selected the 6 h time point to identify genes regulated directly downstream of IL-1 receptor signaling, as opposed to those that may be induced in response to the plethora of autocrine factors secreted by the cells in response to IL-1α stimulation (<xref rid="bb0165" ref-type="bibr">Turner et al., 2009</xref>). It is plausible therefore that the long-term changes in collagen expression that have previously been reported in cardiac fibroblasts (<xref rid="bb0145 bb0195" ref-type="bibr">Siwik et al., 2000; Xiao et al., 2008</xref>) are not due to IL-1α stimulation <italic>per se</italic>, but rather occur through an indirect mechanism. The IL-1α-induced changes in mRNA levels of hyaluronan synthase (increase), type VII collagen (increase) and type XV collagen (decrease) are in close agreement with studies using human dermal fibroblasts (<xref rid="bb0025 bb0100 bb0070" ref-type="bibr">Campo et al., 2006; Mauviel et al., 1994; Kivirikko et al., 1999</xref>).</p>
      <p>Previous studies have shown that cardiac fibroblasts and/or CMF express several MMPs including MMP-1, 2, 3, 9, 13 and 14 (<xref rid="bb0125" ref-type="bibr">Porter and Turner, 2009</xref>). Although stimulatory effects of proinflammatory cytokines on MMP-3 and MMP-9 expression in cardiac (myo)fibroblasts have been reported (<xref rid="bb0125" ref-type="bibr">Porter and Turner, 2009</xref>), there are no prior reports that IL-1 or TNFα can induce MMP-1 (collagenase 1) or MMP-10 (stromelysin-2) expression in this cell type. Indeed, neither basal nor induced MMP-10 expression has been previously reported in CMF. We found no evidence of mRNA expression for MMP-7, 8, 13 or 15 in human CMF. However, MMP-13 has previously been reported to be expressed by rat cardiac fibroblasts and its activity and expression increased by IL-1 or reactive oxygen species (<xref rid="bb0145 bb0150" ref-type="bibr">Siwik et al., 2000; Siwik et al., 2001</xref>). Both MMP-7 and MMP-8 expression is evident in mouse and human myocardium (<xref rid="bb0090 bb0085 bb0180" ref-type="bibr">Lindsey et al., 2005; Lindsey et al., 2006; van den Borne et al., 2009</xref>). After MI, MMP-7 expression is localized to cardiomyocytes and macrophages (<xref rid="bb0085" ref-type="bibr">Lindsey et al., 2006</xref>) and MMP-8 expression to infiltrating macrophages and neutrophils (<xref rid="bb0180" ref-type="bibr">van den Borne et al., 2009</xref>). Taking these studies together with our data, it seems unlikely that CMF actually express MMP-7 or MMP-8.</p>
      <p>Our microarray data indicated that human CMF express high levels of mRNA encoding TIMP-1 and TIMP-2, but not TIMP-3. Secretion of TIMP-1 and -2 protein (but not TIMP-3 or -4) was similarly reported recently in cultured neonatal rat cardiac fibroblasts (<xref rid="bb0020" ref-type="bibr">Brown et al., 2007</xref>). In that study, IL-1 increased secreted TIMP-1 levels by 6-fold after 48 h, but did not affect TIMP-2 expression (<xref rid="bb0020" ref-type="bibr">Brown et al., 2007</xref>). Thus, our data using human cells are in general agreement, with 6 h IL-1α treatment inducing a modest 2-fold increase in TIMP-1 mRNA expression, but TIMP-2 mRNA levels remained unaffected. However, conflicting reports also exist. For example IL-1 and TNFα increased TIMP-1 mRNA expression, but decreased TIMP-1 protein secretion in neonatal rat cardiac non-myocytes (presumably mostly cardiac fibroblasts) (<xref rid="bb0080" ref-type="bibr">Li et al., 1999</xref>). In that study, cytokines did not modulate TIMP-2 (mRNA or protein), but reduced TIMP-3 mRNA and protein expression (<xref rid="bb0080" ref-type="bibr">Li et al., 1999</xref>). TIMP-4 was not detected in cardiac non-myocytes, although it was evident in cardiomyocytes (<xref rid="bb0080" ref-type="bibr">Li et al., 1999</xref>). The consensus of these studies is that cardiac fibroblasts express TIMP-1 and TIMP-2, but not TIMP-4, and TIMP-3 expression remains contentious. Although TIMP-1 expression is modulated by proinflammatory cytokines, TIMP-2 expression is not.</p>
      <p>IL-1α treatment reduced ADAMTS1 mRNA and protein expression in CMF. ADAMTS1 is a secreted metalloproteinase that is a potent inhibitor of angiogenesis, due to its ability to bind vascular endothelial growth factor (VEGF), reduce VEGF receptor signaling and consequently reduce endothelial cell proliferation (<xref rid="bb0095" ref-type="bibr">Luque et al., 2003</xref>). IL-1α also stimulates VEGF-A mRNA expression in human CMF (NA Turner, unpublished data). The combined opposing effects of IL-1α on expression of ADAMTS1 (decrease) and VEGF (increase) may therefore be important for promoting neovascularization of the infarcted myocardium. The inhibitory effects of IL-1α on ADAMTS1 expression in CMF contrast with the reported transient increases in ADAMTS1 expression observed in the heart within 3–6 h of myocardial ischemia in rats <italic>in vivo</italic> (<xref rid="bb0110" ref-type="bibr">Nakamura et al., 2004</xref>). These differences may reflect the opposing effects of hypoxia and proinflammatory cytokines on ADAMTS1 expression. For example, hypoxia induces rapid increases in ADAMTS1 expression in endothelial cells, but not skin fibroblasts (<xref rid="bb0055" ref-type="bibr">Hatipoglu et al., 2009</xref>). In chondrosarcoma cells, hypoxia has no modulatory effect, whereas IL-1 reduces ADAMTS1 expression (<xref rid="bb0065" ref-type="bibr">Kalinski et al., 2007</xref>); findings in agreement with our results in CMF. In contrast, proinflammatory cytokines have been reported to increase ADAMTS1 expression in some other cell types (<xref rid="bb0115 bb0015" ref-type="bibr">Ng et al., 2006; Bevitt et al., 2003</xref>). Hence transcriptional regulation of ADAMTS1 is highly dependent on the cell type studied, as well as on the stimulus applied.</p>
      <p>Of the five MMP genes that we studied, MMP-3 was the only one modulated by SB202580 treatment. IL-1α-induced MMP-3 expression was similarly inhibited by the global p38 inhibitor, BIRB-0796. Thus, IL-1α-induced MMP-3 expression likely occurs via a p38α/β-dependent mechanism in human CMF. Whether this reflects increased gene transcription and/or increased mRNA stabilization remains to be determined, but previous studies on dermal fibroblasts have described p38-dependent stabilization of MMP-3 mRNA following cytokine stimulation (<xref rid="bb0140" ref-type="bibr">Reunanen et al., 2002</xref>). We are not aware of any previous studies that have investigated the effects of the global p38 inhibitor BIRB-0796 on MMP expression. Our findings that IL-1α-induced MMP-1 and MMP-10 mRNA expression was inhibited by BIRB-0796 but not SB203580, suggest a key role for p38-γ/δ. BIRB-0796 is a potent and highly specific inhibitor of all four p38 MAPK subtypes (and also JNK2), and has no inhibitory activity against more than 65 other protein kinases when used at 1 μM concentrations (<xref rid="bb0010" ref-type="bibr">Bain et al., 2007</xref>).</p>
      <p>ADAMTS1 expression was significantly reduced by SB203580 and BIRB-0796 treatment, both in the absence and presence of IL-1α stimulation, suggesting that ADAMTS1 expression is positively regulated by p38 MAPK, but negatively regulated by IL-1α, presumably via a p38-independent mechanism. There are very few prior reports describing the signaling pathways that regulate ADAMTS1 expression. Studies in endothelial cells have uncovered roles for protein kinase C in mediating VEGF-induced ADAMTS1 expression (<xref rid="bb0200" ref-type="bibr">Xu et al., 2006</xref>), and the phosphatidylinositol 3-kinase and p38 MAPK pathways in the response to hypoxia (<xref rid="bb0055" ref-type="bibr">Hatipoglu et al., 2009</xref>). The promoter region of the ADAMTS1 gene contains several transcription factor binding sites including three Sp1/Sp3 sites (<xref rid="bb0045" ref-type="bibr">Doyle et al., 2004</xref>) that are potential downstream targets of p38 MAPK (<xref rid="bb0040" ref-type="bibr">D'Addario et al., 2006</xref>).</p>
      <p>A strength of our study was the use of adult human CMF derived from multiple patients, rather than the more frequently used single strain cell lines (often neonatal) of rabbit and rodent cardiac fibroblasts, which can exhibit important differences compared with human cells (<xref rid="bb0125 bb0005" ref-type="bibr">Porter and Turner, 2009; Agocha et al., 1997</xref>). The responses to IL-1α were reproducible across multiple patients, which contrasts with responses to TNFα in these cells which are more variable and appear to depend on the patient donor (<xref rid="bb0130" ref-type="bibr">Porter et al., 2004a</xref>). A limitation of our study was the focus on gene expression and the assumption that changes in mRNA levels are accompanied by changes in protein expression and/or activity. However, for ADAMTS-1 we did confirm that both mRNA and protein levels were similarly modulated by IL-1α. Our strategy of pooling RNA samples from three different patients for the array precluded statistical analysis. It is possible that smaller statistically significant changes were missed using this approach. It is also feasible that some of the larger changes in mRNA expression observed on the array may not have been evident in all three samples. However, all six of the genes that we pursued using real-time RT-PCR proved to be reproducibly modulated by IL-1α.</p>
      <p>In summary, IL-1α treatment had minimal effect on expression of structural ECM proteins in human CMF, but selectively increased expression of several MMPs (1, 3, 9 and 10) and reduced mRNA and protein levels of ADAMTS1. Of these metalloproteinases, expression of MMP-3 and ADAMTS1 was regulated by p38-α/β, whereas MMP-1 and MMP-10 expression appeared to be mediated via p38-γ/δ subtypes. Thus, we have revealed important new insights into the expression profile of structural ECM proteins, ECM proteases and TIMPs in human CMF in response to IL-1α, a proinflammatory cytokine elevated in the heart after MI. Our findings may help to explain some of the key early catabolic processes that occur in the post-MI heart in man.</p>
    </sec>
    <sec sec-type="methods" id="s0035">
      <label>4</label>
      <title>Experimental procedures</title>
      <sec sec-type="materials" id="s0040">
        <label>4.1</label>
        <title>Materials</title>
        <p>Recombinant human IL-1α and TNFα were purchased from Invitrogen (Paisley, UK). SB203580 was purchased from Calbiochem (Nottingham, UK) and BIRB-0796 was provided by the Division of Signal Transduction Therapy at Dundee University (Dundee, Scotland).</p>
      </sec>
      <sec id="s0045">
        <label>4.2</label>
        <title>Cell culture</title>
        <p>Right atrial appendage biopsies from patients undergoing elective coronary artery bypass surgery at the Leeds General Infirmary were obtained following local ethical committee approval and informed patient consent. Primary cultures of cardiac fibroblasts were harvested, characterized as myofibroblasts (α-smooth muscle actin- and vimentin-positive) and cultured as we have described previously (<xref rid="bb0135 bb0175 bb0105" ref-type="bibr">Porter et al., 2004b; Turner et al., 2003; Mughal et al., 2009</xref>). Experiments were performed on cells from passages 3–5.</p>
      </sec>
      <sec id="s0050">
        <label>4.3</label>
        <title>RT-PCR microarray</title>
        <p>CMF from 3 patients were treated with or without 10 ng/ml IL-1α for 6 h. We selected this concentration based on our previous report describing the optimal IL-1α concentration for inducing proinflammatory cytokine expression in these cells (<xref rid="bb0165" ref-type="bibr">Turner et al., 2009</xref>). Cellular RNA was extracted and pooled before reverse transcription (<xref rid="bb0170" ref-type="bibr">Turner et al., 2007</xref>). Expression levels of 41 structural ECM proteins, ECM proteases and TIMPs were assessed using a focused SYBR Green-based real-time PCR microarray (RT<sup>2</sup> Profiler Human Extracellular Matrix and Adhesion Molecules, SABiosciences, <ext-link ext-link-type="uri" xlink:href="http://www.sabiosciences.com">www.sabiosciences.com</ext-link>). Expression data are presented as percentage of GAPDH expression using the formula 2<sup>−</sup><sup>∆CT</sup> × 100. For undetectable transcripts, calculation of fold increase assumed the detection limit of the array was 15 cycles more than the housekeeping gene average (~ 0.003% GAPDH).</p>
      </sec>
      <sec id="s0055">
        <label>4.4</label>
        <title>Quantitative RT-PCR</title>
        <p>For expression studies, cells from 4 patients were treated with 10 ng/ml IL-1α or TNFα for appropriate times (2–6 h). For inhibitor studies, cells from 5 patients were pre-treated with vehicle (1% DMSO), 10 μM SB203580 or 1 μM BIRB-0796 for 1 h before addition of 10 ng/ml IL-1α for 6 h. After incubation, total RNA was extracted and cDNA prepared as described previously (<xref rid="bb0170" ref-type="bibr">Turner et al., 2007</xref>). Real-time RT-PCR was performed using an Applied Biosystems 7500 Real-Time PCR System and intron-spanning human MMP-1, MMP-2, MMP-3, MMP-9, MMP-10 and ADAMTS1 primers and Taqman probes (Applied Biosystems), as described in <xref rid="s0080" ref-type="sec">Supplementary Table 1</xref>. Data are expressed as percentage of GAPDH endogenous control levels (Hs99999905_m1 primers) using the formula 2<sup>−</sup><sup>∆CT</sup> × 100, in which C<sub>T</sub> is the threshold cycle number.</p>
      </sec>
      <sec id="s0060">
        <label>4.5</label>
        <title>Western blotting</title>
        <p>Whole cell homogenates were prepared as described previously (<xref rid="bb0160" ref-type="bibr">Turner et al., 2001</xref>). ADAMTS1 protein expression was determined using a rabbit anti-human ADAMTS1 polyclonal antibody (A4851; Sigma, Poole, UK) raised against the propeptide region of the human ADAMTS1 zymogen (apparent molecular weight 110–120 kDa). Equal protein loading was confirmed with mouse anti-β-actin monoclonal antibody (ab8226; Abcam, Cambridge, UK). Phosphorylation of p38 MAPK(Thr180/Tyr182) and HSP27(Ser82) was determined by immunoblotting with rabbit phospho-specific polyclonal antibodies (#9211 and #2401; Cell Signaling Technology, Hitchin, UK). Membranes were re-probed with mouse monoclonal p38 MAPK and HSP27 expression antibodies (#9217 and #2402; Cell Signaling Technology) to confirm equal protein loading.</p>
      </sec>
      <sec id="s0065">
        <label>4.6</label>
        <title>Statistical analysis</title>
        <p>Results are mean ± SEM with <italic>n</italic> representing the number of experiments on cells from different patients. Data were analyzed as ratios using repeated measures one-way ANOVA and Newman–Keuls post hoc test (GraphPad Prism software, <ext-link ext-link-type="uri" xlink:href="http://www.graphpad.com">www.graphpad.com</ext-link>). <italic>P</italic> &lt; 0.05 was considered statistically significant.</p>
      </sec>
    </sec>
    <sec id="s0070">
      <title>Disclosure statement</title>
      <p>None.</p>
    </sec>
    <sec id="s0075">
      <title>Role of the funding source</title>
      <p>The work was funded by a project grant from the British Heart Foundation. The funding source had no direct involvement in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bb0005">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Agocha</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sigel</surname>
              <given-names>A.V.</given-names>
            </name>
            <name>
              <surname>Eghbali-Webb</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of adult human heart fibroblasts in culture: a comparative study of growth, proliferation and collagen production in human and rabbit cardiac fibroblasts and their response to transforming growth factor-beta<sub>1</sub></article-title>
          <source>Cell Tissue Res.</source>
          <volume>288</volume>
          <year>1997</year>
          <fpage>87</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="pmid">9042775</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0010">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bain</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Plater</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Elliott</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Shpiro</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Hastie</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>McLauchlan</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Klevernic</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Arthur</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Alessi</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>The selectivity of protein kinase inhibitors: a further update</article-title>
          <source>Biochem. J.</source>
          <volume>408</volume>
          <year>2007</year>
          <fpage>297</fpage>
          <lpage>315</lpage>
          <pub-id pub-id-type="pmid">17850214</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0015">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bevitt</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Mohamed</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Catterall</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Arris</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Hiscott</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Sheridan</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Langton</surname>
              <given-names>K.P.</given-names>
            </name>
            <name>
              <surname>Barker</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>McKie</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Expression of ADAMTS metalloproteinases in the retinal pigment epithelium derived cell line ARPE-19: transcriptional regulation by TNFα</article-title>
          <source>Biochim. Biophys. Acta</source>
          <volume>1626</volume>
          <year>2003</year>
          <fpage>83</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">12697333</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0020">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Laird</surname>
              <given-names>R.E.</given-names>
            </name>
            <name>
              <surname>Hudson</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Long</surname>
              <given-names>C.S.</given-names>
            </name>
          </person-group>
          <article-title>Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <volume>362</volume>
          <year>2007</year>
          <fpage>200</fpage>
          <lpage>205</lpage>
          <pub-id pub-id-type="pmid">17706606</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0025">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Campo</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Avenoso</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Campo</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Angela</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ferlazzo</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Calatroni</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>TNF-α, IFN-γ, and IL-1β modulate hyaluronan synthase expression in human skin fibroblasts: synergistic effect by concomital treatment with FeSO<sub>4</sub> plus ascorbate</article-title>
          <source>Mol. Cell. Biochem.</source>
          <volume>292</volume>
          <year>2006</year>
          <fpage>169</fpage>
          <lpage>178</lpage>
          <pub-id pub-id-type="pmid">16786194</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0030">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Kono</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Golenbock</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Akira</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Rock</surname>
              <given-names>K.L.</given-names>
            </name>
          </person-group>
          <article-title>Identification of a key pathway required for the sterile inflammatory response triggered by dying cells</article-title>
          <source>Nat. Med.</source>
          <volume>13</volume>
          <year>2007</year>
          <fpage>851</fpage>
          <lpage>856</lpage>
          <pub-id pub-id-type="pmid">17572686</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0035">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clark</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Sarafraz</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Marber</surname>
              <given-names>M.S.</given-names>
            </name>
          </person-group>
          <article-title>Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease</article-title>
          <source>Pharmacol. Ther.</source>
          <volume>116</volume>
          <year>2007</year>
          <fpage>192</fpage>
          <lpage>206</lpage>
          <pub-id pub-id-type="pmid">17765316</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0040">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D'Addario</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Arora</surname>
              <given-names>P.D.</given-names>
            </name>
            <name>
              <surname>McCulloch</surname>
              <given-names>C.A.</given-names>
            </name>
          </person-group>
          <article-title>Role of p38 in stress activation of Sp1</article-title>
          <source>Gene</source>
          <volume>379</volume>
          <year>2006</year>
          <fpage>51</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="pmid">16797880</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0045">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Doyle</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Russell</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Sriraman</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Richards</surname>
              <given-names>J.S.</given-names>
            </name>
          </person-group>
          <article-title>Coordinate transcription of the ADAMTS-1 gene by luteinizing hormone and progesterone receptor</article-title>
          <source>Mol. Endocrinol.</source>
          <volume>18</volume>
          <year>2004</year>
          <fpage>2463</fpage>
          <lpage>2478</lpage>
          <pub-id pub-id-type="pmid">15256533</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0050">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guillen</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Blanes</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gomez-Lechon</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Castell</surname>
              <given-names>J.V.</given-names>
            </name>
          </person-group>
          <article-title>Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6</article-title>
          <source>Am. J. Physiol.</source>
          <volume>269</volume>
          <year>1995</year>
          <fpage>R229</fpage>
          <lpage>R235</lpage>
          <pub-id pub-id-type="pmid">7544543</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0055">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hatipoglu</surname>
              <given-names>O.F.</given-names>
            </name>
            <name>
              <surname>Hirohata</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cilek</surname>
              <given-names>M.Z.</given-names>
            </name>
            <name>
              <surname>Ogawa</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Miyoshi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Obika</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Demircan</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Shinohata</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kusachi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ninomiya</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>ADAMTS1 is a unique hypoxic early response gene expressed by endothelial cells</article-title>
          <source>J. Biol. Chem.</source>
          <volume>284</volume>
          <year>2009</year>
          <fpage>16325</fpage>
          <lpage>16333</lpage>
          <pub-id pub-id-type="pmid">19349275</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0060">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Isoda</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kamezawa</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Tada</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ohsuzu</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Myocardial hypertrophy in transgenic mice overexpressing human interleukin 1α</article-title>
          <source>J. Card. Fail.</source>
          <volume>7</volume>
          <year>2001</year>
          <fpage>355</fpage>
          <lpage>364</lpage>
          <pub-id pub-id-type="pmid">11782860</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0065">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kalinski</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Krueger</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sel</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Werner</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ropke</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Roessner</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>ADAMTS1 is regulated by interleukin-1β, not by hypoxia, in chondrosarcoma</article-title>
          <source>Hum. Pathol.</source>
          <volume>38</volume>
          <year>2007</year>
          <fpage>86</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="pmid">16949904</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0070">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kivirikko</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mauviel</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Pihlajaniemi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Uitto</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Cytokine modulation of type XV collagen gene expression in human dermal fibroblast cultures</article-title>
          <source>Exp. Dermatol.</source>
          <volume>8</volume>
          <year>1999</year>
          <fpage>407</fpage>
          <lpage>412</lpage>
          <pub-id pub-id-type="pmid">10536968</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0075">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuma</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sabio</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Bain</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Shpiro</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Márquez</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Cuenda</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo</article-title>
          <source>J. Biol. Chem.</source>
          <volume>280</volume>
          <year>2005</year>
          <fpage>19472</fpage>
          <lpage>19479</lpage>
          <pub-id pub-id-type="pmid">15755732</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0080">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Y.Y.</given-names>
            </name>
            <name>
              <surname>McTiernan</surname>
              <given-names>C.F.</given-names>
            </name>
            <name>
              <surname>Feldman</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>42</volume>
          <year>1999</year>
          <fpage>162</fpage>
          <lpage>172</lpage>
          <pub-id pub-id-type="pmid">10435007</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0085">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lindsey</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Escobar</surname>
              <given-names>G.P.</given-names>
            </name>
            <name>
              <surname>Mukherjee</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Goshorn</surname>
              <given-names>D.K.</given-names>
            </name>
            <name>
              <surname>Sheats</surname>
              <given-names>N.J.</given-names>
            </name>
            <name>
              <surname>Bruce</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Mains</surname>
              <given-names>I.M.</given-names>
            </name>
            <name>
              <surname>Hendrick</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Hewett</surname>
              <given-names>K.W.</given-names>
            </name>
            <name>
              <surname>Gourdie</surname>
              <given-names>R.G.</given-names>
            </name>
            <name>
              <surname>Matrisian</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>Spinale</surname>
              <given-names>F.G.</given-names>
            </name>
          </person-group>
          <article-title>Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction</article-title>
          <source>Circulation</source>
          <volume>113</volume>
          <year>2006</year>
          <fpage>2919</fpage>
          <lpage>2928</lpage>
          <pub-id pub-id-type="pmid">16769909</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0090">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lindsey</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Goshorn</surname>
              <given-names>D.K.</given-names>
            </name>
            <name>
              <surname>Squires</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Escobar</surname>
              <given-names>G.P.</given-names>
            </name>
            <name>
              <surname>Hendrick</surname>
              <given-names>J.W.</given-names>
            </name>
            <name>
              <surname>Mingoia</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Sweterlitsch</surname>
              <given-names>S.E.</given-names>
            </name>
            <name>
              <surname>Spinale</surname>
              <given-names>F.G.</given-names>
            </name>
          </person-group>
          <article-title>Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>66</volume>
          <year>2005</year>
          <fpage>410</fpage>
          <lpage>419</lpage>
          <pub-id pub-id-type="pmid">15820210</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0095">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luque</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Carpizo</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Iruela-Arispe</surname>
              <given-names>M.L.</given-names>
            </name>
          </person-group>
          <article-title>ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165</article-title>
          <source>J. Biol. Chem.</source>
          <volume>278</volume>
          <year>2003</year>
          <fpage>23656</fpage>
          <lpage>23665</lpage>
          <pub-id pub-id-type="pmid">12716911</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0100">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mauviel</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lapiere</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Halcin</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Uitto</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Differential cytokine regulation of type I and type VII collagen gene expression in cultured human dermal fibroblasts</article-title>
          <source>J. Biol. Chem.</source>
          <volume>269</volume>
          <year>1994</year>
          <fpage>25</fpage>
          <lpage>28</lpage>
          <pub-id pub-id-type="pmid">8276802</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0105">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mughal</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Warburton</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>O'Regan</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Ball</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Porter</surname>
              <given-names>K.E.</given-names>
            </name>
          </person-group>
          <article-title>Peroxisome proliferator-activated receptor γ-independent effects of thiazolidinediones on human cardiac myofibroblast function</article-title>
          <source>Clin. Exp. Pharmacol. Physiol.</source>
          <volume>36</volume>
          <year>2009</year>
          <fpage>478</fpage>
          <lpage>486</lpage>
          <pub-id pub-id-type="pmid">19673929</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0110">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakamura</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hirohata</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Murakami</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Miyoshi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Demircan</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Oohashi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ogawa</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Koten</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Toeda</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kusachi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ninomiya</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Shiratori</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Dynamic induction of ADAMTS1 gene in the early phase of acute myocardial infarction</article-title>
          <source>J. Biochem.</source>
          <volume>136</volume>
          <year>2004</year>
          <fpage>439</fpage>
          <lpage>446</lpage>
          <pub-id pub-id-type="pmid">15625312</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0115">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ng</surname>
              <given-names>Y.H.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Pallen</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>P.C.</given-names>
            </name>
            <name>
              <surname>MacCalman</surname>
              <given-names>C.D.</given-names>
            </name>
          </person-group>
          <article-title>Differential effects of interleukin-1β and transforming growth factor-β1 on the expression of the inflammation-associated protein, ADAMTS-1, in human decidual stromal cells in vitro</article-title>
          <source>Hum. Reprod.</source>
          <volume>21</volume>
          <year>2006</year>
          <fpage>1990</fpage>
          <lpage>1999</lpage>
          <pub-id pub-id-type="pmid">16675485</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0120">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishikawa</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kusuhara</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ishigami</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Isoda</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Miyazaki</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ohsuzu</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Left ventricular hypertrophy in mice with a cardiac-specific overexpression of interleukin-1</article-title>
          <source>Am. J. Physiol. Heart Circ. Physiol.</source>
          <volume>291</volume>
          <year>2006</year>
          <fpage>H176</fpage>
          <lpage>H183</lpage>
          <pub-id pub-id-type="pmid">16473963</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0125">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Porter</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>N.A.</given-names>
            </name>
          </person-group>
          <article-title>Cardiac fibroblasts: at the heart of myocardial remodeling</article-title>
          <source>Pharmacol. Ther.</source>
          <volume>123</volume>
          <year>2009</year>
          <fpage>255</fpage>
          <lpage>278</lpage>
          <pub-id pub-id-type="pmid">19460403</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0130">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Porter</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>O'Regan</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Ball</surname>
              <given-names>S.G.</given-names>
            </name>
          </person-group>
          <article-title>Tumor necrosis factor α induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>64</volume>
          <year>2004</year>
          <fpage>507</fpage>
          <lpage>515</lpage>
          <pub-id pub-id-type="pmid">15537504</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0135">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Porter</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>O'Regan</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Balmforth</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Ball</surname>
              <given-names>S.G.</given-names>
            </name>
          </person-group>
          <article-title>Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>61</volume>
          <year>2004</year>
          <fpage>745</fpage>
          <lpage>755</lpage>
          <pub-id pub-id-type="pmid">14985071</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0140">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reunanen</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S.P.</given-names>
            </name>
            <name>
              <surname>Ahonen</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Foschi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kahari</surname>
              <given-names>V.M.</given-names>
            </name>
          </person-group>
          <article-title>Activation of p38α MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization</article-title>
          <source>J. Biol. Chem.</source>
          <volume>277</volume>
          <year>2002</year>
          <fpage>32360</fpage>
          <lpage>32368</lpage>
          <pub-id pub-id-type="pmid">12060661</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0145">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Siwik</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Colucci</surname>
              <given-names>W.S.</given-names>
            </name>
          </person-group>
          <article-title>Interleukin-1β and tumor necrosis factor-α decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro</article-title>
          <source>Circ. Res.</source>
          <volume>86</volume>
          <year>2000</year>
          <fpage>1259</fpage>
          <lpage>1265</lpage>
          <pub-id pub-id-type="pmid">10864917</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0150">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Siwik</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Pagano</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Colucci</surname>
              <given-names>W.S.</given-names>
            </name>
          </person-group>
          <article-title>Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts</article-title>
          <source>Am. J. Physiol. Cell Physiol.</source>
          <volume>280</volume>
          <year>2001</year>
          <fpage>C53</fpage>
          <lpage>C60</lpage>
          <pub-id pub-id-type="pmid">11121376</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0155">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Timmers</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Sluijter</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>van Keulen</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Hoefer</surname>
              <given-names>I.E.</given-names>
            </name>
            <name>
              <surname>Nederhoff</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Goumans</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Doevendans</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>van Echteld</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Joles</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Quax</surname>
              <given-names>P.H.</given-names>
            </name>
            <name>
              <surname>Piek</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Pasterkamp</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>de Kleijn</surname>
              <given-names>D.P.</given-names>
            </name>
          </person-group>
          <article-title>Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction</article-title>
          <source>Circ. Res.</source>
          <volume>102</volume>
          <year>2008</year>
          <fpage>257</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="pmid">18007026</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0160">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turner</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Ball</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Balmforth</surname>
              <given-names>A.J.</given-names>
            </name>
          </person-group>
          <article-title>The mechanism of angiotensin II-induced extracellular signal-regulated kinase-1/2 activation is independent of angiotensin AT<sub>1A</sub> receptor internalisation</article-title>
          <source>Cell. Signal.</source>
          <volume>13</volume>
          <year>2001</year>
          <fpage>269</fpage>
          <lpage>277</lpage>
          <pub-id pub-id-type="pmid">11306244</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0165">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turner</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Warburton</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>O'Regan</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Ball</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Porter</surname>
              <given-names>K.E.</given-names>
            </name>
          </person-group>
          <article-title>Interleukin-1α stimulates pro-inflammatory cytokine expression in human cardiac myofibroblasts</article-title>
          <source>Am. J. Physiol. Heart Circ. Physiol.</source>
          <volume>297</volume>
          <year>2009</year>
          <fpage>H1117</fpage>
          <lpage>H1127</lpage>
          <pub-id pub-id-type="pmid">19648252</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0170">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turner</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Mughal</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Warburton</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>O'Regan</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Ball</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Porter</surname>
              <given-names>K.E.</given-names>
            </name>
          </person-group>
          <article-title>Mechanism of TNFα-induced IL-1α, IL-1β and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>76</volume>
          <year>2007</year>
          <fpage>81</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">17612514</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0175">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turner</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Porter</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>W.H.</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>H.L.</given-names>
            </name>
            <name>
              <surname>Ball</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Balmforth</surname>
              <given-names>A.J.</given-names>
            </name>
          </person-group>
          <article-title>Chronic β<sub>2</sub>-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>57</volume>
          <year>2003</year>
          <fpage>784</fpage>
          <lpage>792</lpage>
          <pub-id pub-id-type="pmid">12618240</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0180">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van den Borne</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Cleutjens</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Hanemaaijer</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Creemers</surname>
              <given-names>E.E.</given-names>
            </name>
            <name>
              <surname>Smits</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Daemen</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Blankesteijn</surname>
              <given-names>W.M.</given-names>
            </name>
          </person-group>
          <article-title>Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction</article-title>
          <source>Cardiovasc. Pathol.</source>
          <volume>18</volume>
          <year>2009</year>
          <fpage>37</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="pmid">18402833</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0185">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van den Borne</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Diez</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Blankesteijn</surname>
              <given-names>W.M.</given-names>
            </name>
            <name>
              <surname>Verjans</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Hofstra</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Narula</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Myocardial remodeling after infarction: the role of myofibroblasts</article-title>
          <source>Nat. Rev. Cardiol.</source>
          <volume>7</volume>
          <year>2010</year>
          <fpage>30</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="pmid">19949426</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0190">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Westphal</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Pilowski</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ebelt</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Muller-Werdan</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Werdan</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Loppnow</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Endotoxin-activated cultured neonatal rat cardiomyocytes express functional surface-associated interleukin-1α</article-title>
          <source>J. Endotoxin Res.</source>
          <volume>13</volume>
          <year>2007</year>
          <fpage>25</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="pmid">17621543</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0195">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xiao</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z.L.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>X.D.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>A.H.</given-names>
            </name>
          </person-group>
          <article-title>Interleukin-1β inhibits collagen synthesis and promotes its decomposition in cultured cardiac fibroblasts</article-title>
          <source>Sheng Li Xue Bao</source>
          <volume>60</volume>
          <year>2008</year>
          <fpage>355</fpage>
          <lpage>361</lpage>
          <pub-id pub-id-type="pmid">18560726</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0200">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Duh</surname>
              <given-names>E.J.</given-names>
            </name>
          </person-group>
          <article-title>Vascular endothelial growth factor upregulates expression of ADAMTS1 in endothelial cells through protein kinase C signaling</article-title>
          <source>Invest. Ophthalmol. Vis. Sci.</source>
          <volume>47</volume>
          <year>2006</year>
          <fpage>4059</fpage>
          <lpage>4066</lpage>
          <pub-id pub-id-type="pmid">16936124</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="s0080" sec-type="supplementary-material">
      <label>Appendix A</label>
      <title>Supplementary data</title>
      <p>
        <supplementary-material content-type="local-data" id="ec0005">
          <caption>
            <title>Supplementary Table 1</title>
            <p>Details of primer sets employed in Taqman real-time RT-PCR assays. All primer/probe sets were purchased from Applied Biosystems.</p>
          </caption>
          <media xlink:href="mmc1.doc" mimetype="application" mime-subtype="msword"/>
        </supplementary-material>
      </p>
    </sec>
    <ack>
      <title>Acknowledgments</title>
      <p>This work was supported by a project grant from the British Heart Foundation (PG/06/012/20287) awarded to N. A. Turner and K. E. Porter. Dr. Turner is the recipient of a Research Councils UK Academic Fellowship. We are grateful to Stacey Galloway for cell culture expertise.</p>
    </ack>
  </back>
  <floats-group>
    <fig id="f0005">
      <label>Fig. 1</label>
      <caption>
        <p>Temporal profile of metalloproteinase mRNA expression in response IL-1α. CMF from 4 patients were exposed to 10 ng/ml IL-1α for 2–6 h before extracting RNA and performing real-time RT-PCR with primers for MMP-1, MMP-2, MMP-3, MMP-9, MMP-10 and ADAMTS1. Data are expressed as percentage relative to GAPDH endogenous control. ANOVA: <italic>P</italic> &lt; 0.001 (MMP-1, MMP-3, MMP-10, ADAMTS1), <italic>P</italic> &lt; 0.01 (MMP-9) and <italic>P</italic> = 0.556 (MMP-2). Newman–Keuls post hoc test: ***<italic>P</italic> &lt; 0.001, **<italic>P</italic> &lt; 0.01, *<italic>P</italic> &lt; 0.05 for effect of IL-1α (<italic>n</italic> = 4).</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="f0010">
      <label>Fig. 2</label>
      <caption>
        <p>Effect of IL-1α on ADAMTS1 protein expression. CMF from 3 patients were treated with 10 ng/ml IL-1α for 2–24 h. Whole cell homogenates were prepared and immunoblotted for ADAMTS1 expression. Blots were reprobed with β-actin antibody to confirm equal protein loading. Representative blots are shown with approximate positions of molecular weight markers (in kDa) to the right. Bar chart depicts pooled densitometry data from different experiments.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="f0015">
      <label>Fig. 3</label>
      <caption>
        <p>Effect of IL-1α and TNFα on metalloproteinase mRNA expression. CMF from 4 patients were exposed to 10 ng/ml TNFα or 10 ng/ml IL-1α (alone or in combination) for 6 h before extracting RNA and performing real-time RT-PCR with primers for MMP-1, MMP-2, MMP-3, MMP-9, MMP-10 and ADAMTS1. Data are expressed as percentage relative to GAPDH endogenous control. Newman–Keuls post hoc test: ***<italic>P</italic> &lt; 0.001, **<italic>P</italic> &lt; 0.01, *<italic>P</italic> &lt; 0.05 for effect of TNFα and/or IL-1α versus vehicle control (<italic>n</italic> = 4).</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="f0020">
      <label>Fig. 4</label>
      <caption>
        <p>IL-1α-induced activation of the p38 MAPK pathway. Following a 1 h pre-treatment with vehicle (1% DMSO), 10 μM SB203580 or 1 μM BIRB-0796, CMF were stimulated without or with 10 ng/ml IL-1α (10 or 20 min) before preparing whole cell homogenates and immunoblotting with phospho-specific and total expression antibodies for p38 MAPK and HSP27. Blots are representative of <italic>n</italic> = 3.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <fig id="f0025">
      <label>Fig. 5</label>
      <caption>
        <p>Effect of p38-α/β MAPK inhibitor SB203580 on metalloproteinase mRNA expression. CMF from 5 different patients were pre-treated with vehicle (1% DMSO) or 10 μM SB203580 before stimulating without (control, C) or with 10 ng/ml IL-1α for 6 h and measuring mRNA levels of MMP-1, MMP-2, MMP-3, MMP-9, MMP-10 and ADAMTS1 by real-time RT-PCR. Data are expressed as percentage relative to GAPDH endogenous control. Newman–Keuls post hoc test: ***<italic>P</italic> &lt; 0.001, **<italic>P</italic> &lt; 0.01, *<italic>P</italic> &lt; 0.05, NS not significant, for effect of IL-1α or inhibitor as indicated (<italic>n</italic> = 5).</p>
      </caption>
      <graphic xlink:href="gr5"/>
    </fig>
    <fig id="f0030">
      <label>Fig. 6</label>
      <caption>
        <p>Effect of p38-α/β/γ/δ MAPK inhibitor BIRB-0796 on metalloproteinase mRNA expression. CMF from the same 5 patients as used for SB203580 experiments were pre-treated with vehicle (1% DMSO) or 1 μM BIRB-0796 before stimulating without (control, C) or with 10 ng/ml IL-1α for 6 h and measuring mRNA levels of metalloproteinases by real-time RT-PCR. Data are expressed as percentage relative to GAPDH endogenous control. Newman–Keuls post hoc test: ***<italic>P</italic> &lt; 0.001, **<italic>P</italic> &lt; 0.01, *<italic>P</italic> &lt; 0.05, NS not significant, for effect of IL-1α or inhibitor as indicated (<italic>n</italic> = 5).</p>
      </caption>
      <graphic xlink:href="gr6"/>
    </fig>
    <table-wrap id="t0005" position="float">
      <label>Table 1</label>
      <caption>
        <p>Effects of IL-1 on mRNA levels of structural ECM proteins. Human CMF from 3 patients treated with 10 ng/ml IL-1α for 6 h before extracting RNA. Pooled RNA was reverse transcribed and analysed by real-time PCR array for 22 ECM proteins.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left">Gene</th>
            <th align="left">Protein</th>
            <th align="left">Basal (% GAPDH)</th>
            <th align="left">IL-1-stimulated (% GAPDH)</th>
            <th align="left">Fold change</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">COL1A1</td>
            <td align="left">Collagen I α1</td>
            <td align="char">181.1</td>
            <td align="char">142.2</td>
            <td align="char">0.79</td>
          </tr>
          <tr>
            <td align="left">COL4A2</td>
            <td align="left">Collagen IV α2</td>
            <td align="char">261.7</td>
            <td align="char">229.1</td>
            <td align="char">0.88</td>
          </tr>
          <tr>
            <td align="left">COL5A1</td>
            <td align="left">Collagen V α1</td>
            <td align="char">115.0</td>
            <td align="char">84.1</td>
            <td align="char">0.73</td>
          </tr>
          <tr>
            <td align="left">COL6A1</td>
            <td align="left">Collagen VI α1</td>
            <td align="char">556.3</td>
            <td align="char">567.8</td>
            <td align="char">1.02</td>
          </tr>
          <tr>
            <td align="left">COL6A2</td>
            <td align="left">Collagen VI α2</td>
            <td align="char">442.3</td>
            <td align="char">430.1</td>
            <td align="char">0.97</td>
          </tr>
          <tr>
            <td align="left">COL7A1</td>
            <td align="left">Collagen VII α1</td>
            <td align="char">1.2</td>
            <td align="char">6.1</td>
            <td align="char">5.08<xref rid="tf0005" ref-type="table-fn">a</xref></td>
          </tr>
          <tr>
            <td align="left">COL8A1</td>
            <td align="left">Collagen VIII α1</td>
            <td align="char">72.2</td>
            <td align="char">59.4</td>
            <td align="char">0.82</td>
          </tr>
          <tr>
            <td align="left">COL11A1</td>
            <td align="left">Collagen XI α1</td>
            <td align="char">0</td>
            <td align="char">0</td>
            <td align="left">–</td>
          </tr>
          <tr>
            <td align="left">COL12A1</td>
            <td align="left">Collagen XII α1</td>
            <td align="char">79.7</td>
            <td align="char">75.8</td>
            <td align="char">0.95</td>
          </tr>
          <tr>
            <td align="left">COL14A1</td>
            <td align="left">Collagen XIV α1</td>
            <td align="char">30.6</td>
            <td align="char">34.3</td>
            <td align="char">1.12</td>
          </tr>
          <tr>
            <td align="left">COL15A1</td>
            <td align="left">Collagen XV α1</td>
            <td align="char">2.1</td>
            <td align="char">0.8</td>
            <td align="char">0.38<xref rid="tf0010" ref-type="table-fn">b</xref></td>
          </tr>
          <tr>
            <td align="left">COL16A1</td>
            <td align="left">Collagen XVI α1</td>
            <td align="char">8.8</td>
            <td align="char">17.1</td>
            <td align="char">1.94</td>
          </tr>
          <tr>
            <td align="left">ECM1</td>
            <td align="left">Extracellular matrix protein 1</td>
            <td align="char">2.4</td>
            <td align="char">2.4</td>
            <td align="char">1.00</td>
          </tr>
          <tr>
            <td align="left">FN1</td>
            <td align="left">Fibronectin 1</td>
            <td align="char">5567.7</td>
            <td align="char">5474.1</td>
            <td align="char">0.98</td>
          </tr>
          <tr>
            <td align="left">HAS1</td>
            <td align="left">Hyaluronan synthase 1</td>
            <td align="char">0.2</td>
            <td align="char">1.5</td>
            <td align="char">7.50<xref rid="tf0005" ref-type="table-fn">a</xref></td>
          </tr>
          <tr>
            <td align="left">LAMA1</td>
            <td align="left">Laminin α1</td>
            <td align="char">0.4</td>
            <td align="char">0.1</td>
            <td align="char">0.25<xref rid="tf0010" ref-type="table-fn">b</xref></td>
          </tr>
          <tr>
            <td align="left">LAMA2</td>
            <td align="left">Laminin α2</td>
            <td align="char">17.0</td>
            <td align="char">13.3</td>
            <td align="char">0.78</td>
          </tr>
          <tr>
            <td align="left">LAMA3</td>
            <td align="left">Laminin α3</td>
            <td align="char">2.3</td>
            <td align="char">3.9</td>
            <td align="char">1.70</td>
          </tr>
          <tr>
            <td align="left">LAMB1</td>
            <td align="left">Laminin β1</td>
            <td align="char">92.0</td>
            <td align="char">49.6</td>
            <td align="char">0.54</td>
          </tr>
          <tr>
            <td align="left">LAMB3</td>
            <td align="left">Laminin β3</td>
            <td align="char">1.0</td>
            <td align="char">2.1</td>
            <td align="char">2.10<xref rid="tf0005" ref-type="table-fn">a</xref></td>
          </tr>
          <tr>
            <td align="left">LAMC1</td>
            <td align="left">Laminin γ1</td>
            <td align="char">79.8</td>
            <td align="char">102.8</td>
            <td align="char">1.23</td>
          </tr>
          <tr>
            <td align="left">VCAN</td>
            <td align="left">Versican</td>
            <td align="char">145.4</td>
            <td align="char">75.3</td>
            <td align="char">0.52</td>
          </tr>
          <tr>
            <td align="left">VTN</td>
            <td align="left">Vitronectin</td>
            <td align="char">5.7</td>
            <td align="char">5.5</td>
            <td align="char">0.96</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tf0005">
          <label>a</label>
          <p>Indicates marked increase (≥ 2 × control).</p>
        </fn>
      </table-wrap-foot>
      <table-wrap-foot>
        <fn id="tf0010">
          <label>b</label>
          <p>Indicates marked decrease (≤ 0.5 × control).</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="t0010" position="float">
      <label>Table 2</label>
      <caption>
        <p>Effects of IL-1α on mRNA levels of ECM proteases and TIMPs. Human CMF from 3 patients treated with 10 ng/ml IL-1α for 6 h before extracting RNA. Pooled RNA was reverse transcribed and analyzed by real-time PCR array for 12 MMPs and 3 TIMPs. Fold increases for non-detectable samples assume a detection limit of 0.003% GAPDH.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left">Gene</th>
            <th align="left">Protein pseudonym</th>
            <th align="left">Basal (% GAPDH)</th>
            <th align="left">IL-1-stimulated (% GAPDH)</th>
            <th align="left">Fold change</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">ADAMTS1</td>
            <td align="left">METH-1</td>
            <td align="char">260.6</td>
            <td align="char">92.2</td>
            <td align="char">0.4<xref rid="tf0020" ref-type="table-fn">b</xref></td>
          </tr>
          <tr>
            <td align="left">ADAMTS8</td>
            <td align="left">METH-2</td>
            <td align="char">0.7</td>
            <td align="char">0.7</td>
            <td align="char">1.0</td>
          </tr>
          <tr>
            <td align="left">ADAMTS13</td>
            <td align="left">vWF-CP</td>
            <td align="char">0.3</td>
            <td align="center">–</td>
            <td align="char">0.01<xref rid="tf0020" ref-type="table-fn">b</xref></td>
          </tr>
          <tr>
            <td align="left">MMP1</td>
            <td align="left">Collagenase 1</td>
            <td align="char">20.7</td>
            <td align="char">167.8</td>
            <td align="char">8.1<xref rid="tf0015" ref-type="table-fn">a</xref></td>
          </tr>
          <tr>
            <td align="left">MMP2</td>
            <td align="left">Gelatinase A</td>
            <td align="char">144.0</td>
            <td align="char">128.9</td>
            <td align="char">0.9</td>
          </tr>
          <tr>
            <td align="left">MMP3</td>
            <td align="left">Stromelysin 1</td>
            <td align="center">–</td>
            <td align="char">0.46</td>
            <td align="char">153.3<xref rid="tf0015" ref-type="table-fn">a</xref></td>
          </tr>
          <tr>
            <td align="left">MMP7</td>
            <td align="left">Matrilysin 1</td>
            <td align="center">–</td>
            <td align="center">–</td>
            <td align="center">–</td>
          </tr>
          <tr>
            <td align="left">MMP8</td>
            <td align="left">Collagenase 2</td>
            <td align="center">–</td>
            <td align="center">–</td>
            <td align="center">–</td>
          </tr>
          <tr>
            <td align="left">MMP9</td>
            <td align="left">Gelatinase B</td>
            <td align="center">–</td>
            <td align="char">0.62</td>
            <td align="char">206.7<xref rid="tf0015" ref-type="table-fn">a</xref></td>
          </tr>
          <tr>
            <td align="left">MMP10</td>
            <td align="left">Stromelysin 2</td>
            <td align="char">0.31</td>
            <td align="char">27.4</td>
            <td align="char">88.4<xref rid="tf0015" ref-type="table-fn">a</xref></td>
          </tr>
          <tr>
            <td align="left">MMP11</td>
            <td align="left">Stromelysin 3</td>
            <td align="char">0.73</td>
            <td align="char">0.38</td>
            <td align="char">0.5<xref rid="tf0020" ref-type="table-fn">b</xref></td>
          </tr>
          <tr>
            <td align="left">MMP13</td>
            <td align="left">Collagenase 3</td>
            <td align="center">–</td>
            <td align="center">–</td>
            <td align="center">–</td>
          </tr>
          <tr>
            <td align="left">MMP14</td>
            <td align="left">MT1-MMP</td>
            <td align="char">9.9</td>
            <td align="char">13.0</td>
            <td align="char">1.3</td>
          </tr>
          <tr>
            <td align="left">MMP15</td>
            <td align="left">MT2-MMP</td>
            <td align="center">–</td>
            <td align="center">–</td>
            <td align="center">–</td>
          </tr>
          <tr>
            <td align="left">MMP16</td>
            <td align="left">MT3-MMP</td>
            <td align="char">6.6</td>
            <td align="char">2.0</td>
            <td align="char">0.3<xref rid="tf0020" ref-type="table-fn">b</xref></td>
          </tr>
          <tr>
            <td align="left">TIMP1</td>
            <td/>
            <td align="char">2210.0</td>
            <td align="char">4403.4</td>
            <td align="char">2.0<xref rid="tf0015" ref-type="table-fn">a</xref></td>
          </tr>
          <tr>
            <td align="left">TIMP2</td>
            <td/>
            <td align="char">644.9</td>
            <td align="char">600.7</td>
            <td align="char">0.9</td>
          </tr>
          <tr>
            <td align="left">TIMP3</td>
            <td/>
            <td align="center">–</td>
            <td align="center">–</td>
            <td align="center">–</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tf0015">
          <label>a</label>
          <p>Indicates marked increase (≥ 2 × control).</p>
        </fn>
      </table-wrap-foot>
      <table-wrap-foot>
        <fn id="tf0020">
          <label>b</label>
          <p>Indicates marked decrease (≤ 0.5 × control).</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>